Biologic Therapies VII Summit: Precision Medicine in the Biologic Era

Biologic Therapies VII Summit is an advanced course that brings together world leaders in immune-based therapies and addresses cutting-edge translational immunology and the latest data on biologic therapeutics. This year’s Summit will focus on precision medicine and kicks off with a fundamental immunologic plenary session, reviewing recent basic laboratory breakthroughs in terms of their potential clinical implications. The Biologic Crossfire session will provide critical insights into new pathways and shared challenges for multiple disciplines engaged in the use of biologic therapies.

Objectives

• Describe recent advances in biologic drug development, regulations, and indications in immune-mediated inflammatory diseases (IMIDs).
• Critically appraise data on genetics and personalized medicine as applied to rheumatic diseases and IMIDs.
• Analyze recent investigations on efficacy and toxicity of biologic agents across IMIDS.
• Detail current knowledge related to predicting outcomes in patients with rheumatoid arthritis (RA).
• Summarize updates in diagnosis, classification, therapies, and immune-system targets in both psoriatic arthritis (PsA) and spondyloarthopathies (SpA) and describe their clinical implications.
• Critically assess clinical data on biologic use in immune-related diseases in the areas of pulmonary disease, dermatology, metabolic bone diseases, and systemic lupus erythematosus (SLE).
• Develop strategies to predict, prevent, and treat comorbid complications of biologic therapy including cardiovascular disease and serious infections.